 Heres a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks Biotech Stocks Hitting 52-week highs on Feb. 19 Adverum Biotechnologies Inc NASDAQ: ADVM Akebia Therapeutics Inc NASDAQ: AKBA Anavex Life Sciences Corp NASDAQ: AVXL Arcus Biosciences Inc NYSE: RCUS Ascendis Pharma AS NASDAQ: ASND AVITA MED LTDS ADR NASDAQ: RCEL reacted to its half-yearly results Bio-Rad Laboratories, Inc. Class A NYSE: BIO Calithera Biosciences Inc NASDAQ: CALA ChemoCentryx Inc NASDAQ: CCXI Cue Biopharma Inc NASDAQ: CUE said its therapeutic Immuno-STAT platform will be featured in a Merck Co., Inc.s NYSE: MRK presentation at the Antigen Specific Immune Tolerance Drug Development Summit DexCom, Inc. NASDAQ: DXCM Fate Therapeutics Inc NASDAQ: FATE Fulgent Genetics Inc NASDAQ: FLGT GALAPAGOS NVS ADR NASDAQ: GLPG GENMAB ASS ADR NASDAQ: GMAB reacted to its quarterly and full-year results Grifols SA - ADR ADR Class B NASDAQ: GRFS Insulet Corporation NASDAQ: PODD Intuitive Surgical, Inc. 